Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.

[1]  W. Nitz,et al.  Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis , 2006, Heart.

[2]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[3]  V. Hombach,et al.  Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy , 2006, European journal of heart failure.

[4]  Timothy G Reese,et al.  Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[5]  H. Sakahara,et al.  Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[7]  Olga Bondarenko,et al.  Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  K. Teraoka.  Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. , 2004, Magnetic resonance imaging.

[9]  Y. Amano,et al.  Delayed hyper‐enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: Comparison with global and regional cardiac MR imaging appearances , 2004, Journal of magnetic resonance imaging : JMRI.

[10]  Robert R Edelman,et al.  Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.

[11]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[12]  D. Pennell,et al.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[13]  L. V. Van Hoe,et al.  Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. , 2004, AJR. American journal of roentgenology.

[14]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[15]  J. Higaki,et al.  First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. , 2003, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[16]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[17]  Jan Bogaert,et al.  Late Myocardial Enhancement in Hypertrophic Cardiomyopathy with Contrast-Enhanced MR Imaging , 2003 .

[18]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[19]  K. Chien,et al.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. , 2003, The Journal of clinical investigation.

[20]  Y. Doi,et al.  Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy. , 2002, Journal of cardiology.

[21]  Katherine C. Wu,et al.  Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.

[22]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[23]  Ali Massumi,et al.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. , 2002, Texas Heart Institute journal.

[24]  P. Elliott,et al.  Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.

[25]  H. Ishibashi-Ueda,et al.  Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy. , 1998, Journal of cardiology.

[26]  N. Ohkubo,et al.  [Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium]. , 1996, Journal of cardiology.

[27]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[28]  D. Berman,et al.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. , 1993, Journal of the American College of Cardiology.

[29]  W. Roberts,et al.  Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[30]  W. Mckenna,et al.  The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.

[31]  H. Ishibashi-Ueda,et al.  Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. , 1985, American heart journal.